Magda Marquet's Insider Trades & SAST Disclosures
Magda Marquet's most recent trade in AnaptysBio Inc was a trade of 16,510 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Magda Marquet.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AnaptysBio Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 6,030 | 6,030 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Magda Marquet | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 3,900 | 0 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Magda Marquet | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 3,900 | 3,900 (0%) | 0% | 0 | Common Stock | |
| TransCode Therapeutics Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Arcturus Therapeutics Hold... | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Hold... | Magda Marquet | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 3,131 | 3,131 (0%) | 0% | 0 | Common Stock | |
| Arcturus Therapeutics Hold... | Magda Marquet | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 3,131 | 0 | - | - | Deferred Stock Units | |
| Immix Biopharma Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) | |
| Immix Biopharma Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 25,002 | 25,002 | - | 0 | Common Stock | |
| Immix Biopharma Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 21,155 | 46,092 | - | - | Common Stock | |
| AnaptysBio Inc | Marquet Magda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Marquet Magda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 6,030 | 6,030 | - | - | Restricted Stock Unit | |
| Immix Biopharma Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 20,000 | 20,000 | - | - | Stock Options | |
| Arcturus Therapeutics Hold... | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 11,869 | 11,869 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Hold... | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 3,131 | 3,131 | - | - | Deferred Stock Units | |
| TransCode Therapeutics Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 9,500 | 9,500 | - | - | Stock Option (Right to Buy) | |
| AnaptysBio Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,900 | 3,900 | - | - | Restricted Stock Unit | |
| Arcturus Therapeutics Hold... | Magda Marquet | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 15 Dec 2022 | 2,222 | 24,942 (0%) | 0% | 18 | 39,996 | Common Stock |
| Immix Biopharma Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 16,000 | 76,000 | - | - | Stock Options | |
| Arcturus Therapeutics Hold... | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| TransCode Therapeutics Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 9,500 | 9,500 | - | - | Stock Option (Right to Buy) | |
| AnaptysBio Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 9,200 | 9,200 | - | - | Stock Option (right to buy) | |
| Arcturus Therapeutics Hold... | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 784 | 784 | - | - | Stock Option (right to buy) | |
| Arcturus Therapeutics Hold... | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 15,000 | 15,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges